A basic understanding of mucopolysaccharidosis: Incidence, clinical features, diagnosis, and management

J Zhou, J Lin, WT Leung, L Wang - Intractable & rare diseases …, 2020 - jstage.jst.go.jp
Mucopolysaccharidoses (MPS) are a group of rare lysosomal storage diseases (LSD)
caused by genetic defects. These genetic defects lead to a lack or deficiency of enzymes …

Inborn errors of metabolism associated with autism spectrum disorders: approaches to intervention

T Žigman, D Petković Ramadža, G Šimić… - Frontiers in …, 2021 - frontiersin.org
Increasing evidence suggests that the autism spectrum disorder (ASD) may be associated
with inborn errors of metabolism, such as disorders of amino acid metabolism and transport …

Roles of the oxytocin receptor (OXTR) in human diseases

K Pierzynowska, L Gaffke, M Żabińska, Z Cyske… - International journal of …, 2023 - mdpi.com
The oxytocin receptor (OXTR), encoded by the OXTR gene, is responsible for the signal
transduction after binding its ligand, oxytocin. Although this signaling is primarily involved in …

[HTML][HTML] ADHD symptoms in neurometabolic diseases: Underlying mechanisms and clinical implications

SC Homaei, H Barone, R Kleppe, N Betari… - … & biobehavioral reviews, 2022 - Elsevier
Neurometabolic diseases (NMDs) are typically caused by genetic abnormalities affecting
enzyme functions, which in turn interfere with normal development and activity of the …

Sanfilippo syndrome: Overall review

F Andrade, L Aldámiz‐Echevarría… - Pediatrics …, 2015 - Wiley Online Library
Abstract Mucopolysaccharidosis type III (MPS III, Sanfilippo syndrome) is a lysosomal
storage disorder, caused by a deficiency in one of the four enzymes involved in the …

Sanfilippo syndrome: consensus guidelines for clinical care

N Muschol, R Giugliani, SA Jones, J Muenzer… - Orphanet Journal of …, 2022 - Springer
Sanfilippo syndrome is a group of rare, complex, and progressive neurodegenerative
lysosomal storage disorders that is characterized by childhood dementia. The clinical …

Molecular bases of neurodegeneration and cognitive decline, the major burden of Sanfilippo disease

R Heon-Roberts, ALA Nguyen… - Journal of Clinical …, 2020 - mdpi.com
The mucopolysaccharidoses (MPS) are a group of diseases caused by the lysosomal
accumulation of glycosaminoglycans, due to genetic deficiencies of enzymes involved in …

Novel therapies for mucopolysaccharidosis type III

B Seker Yilmaz, J Davison, SA Jones… - Journal of inherited …, 2021 - Wiley Online Library
Abstract Mucopolysaccharidosis type III (MPS III) or Sanfilippo disease is an orphan
inherited lysosomal storage disease and one of the most common MPS subtypes. The …

Clinical presentation and diagnosis of mucopolysaccharidoses

M Stapleton, N Arunkumar, F Kubaski… - Molecular genetics and …, 2018 - Elsevier
Mucopolysaccharidoses (MPS) are estimated to affect1 in 25,000 live births although
specific rates vary between the ethnic origin and country. MPS are a group of lysosomal …

Delivering gene therapy for mucopolysaccharide diseases

SR Wood, BW Bigger - Frontiers in Molecular Biosciences, 2022 - frontiersin.org
Mucopolysaccharide diseases are a group of paediatric inherited lysosomal storage
diseases that are caused by enzyme deficiencies, leading to a build-up of …